Cargando…
What matters to patients and clinicians when discussing the impact of cancer medicines on health-related quality of life? Consensus-based mixed methods approach in prostate cancer
OBJECTIVE: To identify what matters to clinicians and patients when discussing cancer medicines’ impact on health-related quality of life (HRQoL). METHODS: A framework of HRQoL domain/domain elements was developed, informed by analysis of published patient reported outcome measures (PROMs), applicab...
Autores principales: | Dunlop, Emma, Ferguson, Aimee, Mueller, Tanja, Baillie, Kelly, Clarke, Julie, Laskey, Jennifer, Kurdi, Amanj, Wu, Olivia, Jones, Rob, Glen, Hilary, Bennie, Marion |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8857102/ https://www.ncbi.nlm.nih.gov/pubmed/34878587 http://dx.doi.org/10.1007/s00520-021-06724-6 |
Ejemplares similares
-
Use of record linkage to evaluate treatment outcomes and trial eligibility in a real‐world metastatic prostate cancer population in Scotland
por: Baillie, Kelly, et al.
Publicado: (2020) -
Healthcare Costs for Metastatic Castration-Resistant Prostate Cancer Patients Treated with Abiraterone or Enzalutamide
por: Rana, Dikshyanta, et al.
Publicado: (2021) -
Uptake of monoclonal antibodies and antiviral therapies for COVID-19 in Scotland
por: Tibble, Holly, et al.
Publicado: (2023) -
An umbrella review and meta‐analysis of renin–angiotensin system drugs use and COVID‐19 outcomes
por: Kurdi, Amanj, et al.
Publicado: (2022) -
Assessing medication use patterns in patients hospitalised with COVID-19: a retrospective study
por: Mueller, Tanja, et al.
Publicado: (2022)